Refractory livedoid vasculopathy successfully treated with baricitinib. Xiao Y, Wang Y, Gu Y, Xia D, et al. Int J Dermatol 2023;62:1204-1205.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Xiao Y, Wang Y, Gu Y, Xia D, et al. Refractory livedoid vasculopathy successfully treated with baricitinib. Int J Dermatol 2023;62:1204-1205.
PMID: 36349427